National and local news outlets report on a threating phone call, which prompted OHSU’s Richmond Clinic to evacuate on Thursday, August 3. Additional security measures have been put in place at Richmond and OHSU is offering resources and support options through the well-being program.

National and local news outlets report on a threating phone call, which prompted OHSU’s Richmond Clinic to evacuate on Thursday, August 3. Additional security measures have been put in place at Richmond and OHSU is offering resources and support options through the well-being program.

A Becker’s Hospital Review story notes that the OHSU Knight Cancer Institute is one of just seven U.S. News best-cancer hospitals located in states where cancer is the leading cause of death.

This story highlights OHSU’s program to provide RV parking spaces for patients and families. Brett Dodson, director of transportation and parking at OHSU, says in addition to improving patient comfort, the RV spaces set the hospital up to provide better care: “People who previously would have driven through the night to get to Portland for a morning surgery can now arrive the night before. They can get a good night’s sleep, they’d be ready for a surgery, and they’re there on time.”

ALS News Today highlights OHSU’s role in a new study which explores targeting the gene α5 integrin as an immunomodulatory treatment for the disease.

Lisa Coussens, Ph.D., is appointed to the inaugural Scientific Advisory Board for Shasqi, Inc. a clinical stage biotech company with a mission to revolutionize cancer treatment with click chemistry.

A new OHSU study published in the American Journal of Human Genetics notes that more than 13,000 Oregonians have been screened for genetic diseases including cancer since 2018. First author Timothy O’Brien, Ph.D., says: “We’re hoping that this can really be used as a model for other states that want to do low-cost population screening. We’ve provided a kind of roadmap where up-and-coming screening programs can look at us and see both what worked and what could be improved upon.”

In a Portland Business Journal story about the death of precision medicine advocate, OHSU Knight Cancer Institute supporter and former Intel exec Bryce Olson, Brian Druker, M.D., says: “Bryce was a passionate advocate for matching cancer patients to the treatments most likely to work against their tumor through DNA sequencing. He boiled this field of precision oncology down to two words: ‘Sequence Me.’ His voice will be missed, but his message will not be forgotten.”

A KFF Health News story highlights a recent study led by OHSU revealing that adolescents are rarely offered medication to treat opioid use disorder in U.S. residential treatment facilities. Caroline King, M.D., Ph.D., says, “I’m not sure if inhumane is too strong of a word. Offering nothing, offering no additional medication, even nausea medication or really basic things, is really a travesty.”

This story highlights a recent study led by OHSU revealing that adolescents are rarely offered medication to treat opioid use disorder in U.S. residential treatment facilities. Caroline King, M.D., Ph.D., says, “I’m not sure if inhumane is too strong of a word. Offering nothing, offering no additional medication, even nausea medication or really basic things, is really a travesty.”